Ketamine administration reduces amygdalo-hippocampal reactivity to emotional stimulation.


Increased amygdala reactivity might lead to negative bias during emotional processing that can be reversed by antidepressant drug treatment. However, little is known on how N-methyl-d-aspartate (NMDA) receptor antagonism with ketamine as a novel antidepressant drug target might modulate amygdala reactivity to emotional stimulation. Using functional magnetic… (More)
DOI: 10.1002/hbm.23148


7 Figures and Tables


Citations per Year

Citation Velocity: 25

Averaging 25 citations per year over the last 2 years.

Learn more about how we calculate this metric in our FAQ.